Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
Open Access
- 1 December 2013
- journal article
- review article
- Published by Informa UK Limited in OncoTargets and Therapy
- Vol. 7, 57-68
- https://doi.org/10.2147/ott.s53876
Abstract
Peer reviewed article authored by (Surget S, Khoury MP, Bourdon JC). Read article or submit your manuscript for publishing.Keywords
This publication has 99 references indexed in Scilit:
- Distinct Regulatory Mechanisms and Functions for p53-Activated and p53-Repressed DNA Damage Response Genes in Embryonic Stem CellsMolecular Cell, 2012
- Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activityCell Death & Differentiation, 2011
- Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancerBritish Journal of Cancer, 2011
- Metabolic regulation by p53Journal of Molecular Medicine, 2011
- Heterochromatin silencing of p53 target genes by a small viral proteinNature, 2010
- p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damageCell Death & Differentiation, 2010
- p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescenceNature, 2009
- Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancerEuropean Journal Of Cancer, 2008
- Expression of p53 isoforms in squamous cell carcinoma of the head and neckEuropean Journal Of Cancer, 2007
- The p53 tumour suppressor geneNature, 1991